GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HEXO Corp (FRA:74H) » Definitions » Debt-to-EBITDA

HEXO (FRA:74H) Debt-to-EBITDA : -0.36 (As of Apr. 2023)


View and export this data going back to 2017. Start your Free Trial

What is HEXO Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

HEXO's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2023 was €120.91 Mil. HEXO's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2023 was €0.72 Mil. HEXO's annualized EBITDA for the quarter that ended in Apr. 2023 was €-339.78 Mil. HEXO's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2023 was -0.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for HEXO's Debt-to-EBITDA or its related term are showing as below:

FRA:74H's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.68
* Ranked among companies with meaningful Debt-to-EBITDA only.

HEXO Debt-to-EBITDA Historical Data

The historical data trend for HEXO's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HEXO Debt-to-EBITDA Chart

HEXO Annual Data
Trend Sep14 Sep15 Sep16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only - -0.76 -0.19 -7.53 -0.24

HEXO Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.66 -0.69 -1.44 5.30 -0.36

Competitive Comparison of HEXO's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, HEXO's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HEXO's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HEXO's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HEXO's Debt-to-EBITDA falls into.



HEXO Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

HEXO's Debt-to-EBITDA for the fiscal year that ended in Jul. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(189.665 + 1.464) / -792.346
=-0.24

HEXO's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(120.908 + 0.718) / -339.776
=-0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Apr. 2023) EBITDA data.


HEXO  (FRA:74H) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


HEXO Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HEXO's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HEXO (FRA:74H) Business Description

Traded in Other Exchanges
N/A
Address
120 de la Rive Road, Gatineau, QC, CAN, J8M 1V2
HEXO Corp is engaged in producing and selling cannabis and cannabis products. The company is focused on smoke-free and traditional cannabis products. The firm's products include dried flowers, oils, and vapes. It generates its revenue from various sources such as Beverage Based Adult-Use Sales, Medical, Wholesale and International sales.

HEXO (FRA:74H) Headlines

No Headlines